Gene Query: PLAT

Dataset Description Geneva Score
HNF1 regulates critical functions of the human epididymis epithelium. 281.99
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 281.99
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 164.64
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 164.64
EWSR1 influences alternative splicing through direct and indirect mechanisms 138.07
Statins modulate endothelial transcriptional profile by inhibiting EZH2 135.93
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 124.46
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 117.21
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 106.11
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 104.08
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 99.1
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 98.36
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 83.4
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 83.4
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 81.56
Control of prostate tumour growth by the long non-coding RNA GHSROS 77.87
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 77.03
RNA-seq analyses of human prostate cancer cells 76.55
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 75.32
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 74.17
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 74.17
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 73.0
Differential expression of genes in AD169-infected MRC5. 72.27
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 71.76
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 70.61
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 68.38
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 68.38
Toxoplasma gondii infection of human retinal pigment epithelial cells 67.35
Role of CD133 molecule in WNT response and renal repair 66.87
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 66.84
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 66.82
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 64.9
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 64.14
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 61.89
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 60.81
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 60.05
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 59.78
FOXD3 is a novel tumor suppressor in lung cancer 59.45
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 59.26
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 57.23
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 55.79
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 55.57
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 55.57
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 55.56
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 53.27
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 53.27
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 53.08
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 52.95
RNA-seq of human fibroblasts after irradiation 52.82
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 52.67
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 51.58
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 51.37
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 51.28
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 49.88
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 49.64
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 49.06
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 48.86
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 48.18
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 47.2
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 45.95
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  45.68
Regulation of Lipids is Central to Replicative Senescence 45.49
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 45.46
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 45.39
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 45.29
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 44.9
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 44.5
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 44.37
Evolution of a transcriptional regulator from a transmembrane nucleoporin 44.07
RNA-seq in HepG2 and IMR90 cells 44.07
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 43.68
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 43.6
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 43.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 43.15
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 43.15
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 42.95
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 42.65
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 42.39
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 42.35
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 42.32
Characterization of the Merkel cell carcinoma miRNome 42.28
Rorc disruption in human FG pancreatic cancer cells 41.8
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 41.34
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 41.34
The regulartory role of ZCCHC24 in splicing machinery 41.21
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 40.7
Fbxo32 mediated gene expression program underlies EMT and metastasis 40.67
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 40.14
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 40.1
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 39.6
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 39.35
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 38.96
RNA sequencing of BT142 and TS603 cell lines 38.96
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 38.86
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 38.78
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 38.48
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 38.16
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 38.02
Splicing and epigenetic factors jointly regulate epidermal differentiation 37.94
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 37.92
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 37.69
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 37.69
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 37.37
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 37.37
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 37.15
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 37.15
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 37.15
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 37.0
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 36.84
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 36.31
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 36.31
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 36.23
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 36.1
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 35.89
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 35.59
Gene expression profiling of human and murine in vitro muscle differentiation 35.18
Effect of nuclear IL-33 on gene expression 34.87
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 34.76
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 34.76
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 34.61
Aneuploidy-induced cellular stresses limit autophagic degradation. 34.55
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 34.52
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 34.47
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 34.33
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 34.31
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 34.3
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 34.28
RNA-seq of human aneuploid cell lines with Trisomy 21 34.22
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 33.97
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 33.97
Functional role of SLIT2 and ROBO1 in trophoblasts 33.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 33.66
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 33.39
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 33.39
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 33.35
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 33.35
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 33.22
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 33.17
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 32.75
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 32.68
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 32.4
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 32.39
BI Human Reference Epigenome Mapping Project 32.25
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 32.05
UBC9 knockdown in bladder cancer T24 cell lines 32.02
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 31.81
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 31.77
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 31.23
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 31.0
Global analyses of the effect of different cellular contexts on microRNA targeting 31.0
MYCi975 regulates MYC target genes 30.98
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 30.76
Expression level comparison under dividing and quiescent states in human primary fibroblasts 30.34
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 30.16
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 30.02
Selective suppression of endothelial cytokine production by progesterone receptor 30.02
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 29.97
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 29.54
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 29.26
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 29.25
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 29.23
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 29.22
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 28.98
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 28.89
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 28.89
Identification of the role of polydom in neurofibromas 28.87
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 28.81
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 28.78
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 28.78
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 28.69
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 28.57
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 28.47
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 28.23
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 28.09
6mer seed toxicity in tumour suppressive microRNAs 28.02
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 27.85
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 27.85
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 27.7
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 27.68
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 27.65
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 27.48
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 27.41
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 27.29
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 27.05
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 26.66
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 26.59
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 26.24
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 26.12
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 26.12
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 25.9
DJ-1 is dispensable for human stem cell homeostasis 25.81
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 25.78
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 25.72
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 25.57
Chromatin landscape of human visceral and subcutaneous adipocytes 25.5
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 25.41
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 25.29
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 24.99
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 24.94
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 24.85
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 24.84
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 24.78
Transcriptome profiling of Normal and Cancerous Prostate Cells 24.69
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 24.69
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 24.69
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 24.52
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 24.52
BAF controls genome accessibility 24.2
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.07
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 23.87
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  23.76
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 23.73
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 23.35
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 23.32
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 23.24
Hypoxic transcriptome of SQ20B human head and neck cancer cells 23.23
Effect of Influenza virus infection on lncRNA expression in A549 cells 23.23
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 23.23
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 23.02
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 23.02
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 22.89
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 22.77
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 22.75
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 22.62
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 22.48
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 22.44
Functional role of CPPED1 in trophoblasts. 22.42
RNAseq Analysis in glioblastoma cells treated with Mepazine 22.28
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 22.01
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 21.9
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 21.86
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 21.82
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 21.8
21.64
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 21.44
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 21.43
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 21.43
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 21.4
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 21.31
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 21.22
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 21.22
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 20.96
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 20.89
Transcriptional responses of melanoma cells to BRAF inhibition 20.81
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 20.69
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 20.69
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 20.69
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 20.5
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 20.5
Transcriptome analysis of virus infected tissues 20.19
Generation of trichogenic adipose-derived stem cells by expression of three factors 20.19
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 20.1
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 20.1
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 20.08
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 19.98
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 19.84
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 19.82
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 19.66
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 19.64
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 19.64
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 19.57
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 19.57
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 19.56
Gene expression profile of CRC-derived HILEC 19.27
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 19.27
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 19.25
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 19.25
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 19.24
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 19.21
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 19.19
A practical evaluation of alignment algorithms for RNA variant calling analysis 19.09
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 19.06
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 18.98
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 18.95
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 18.84
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 18.81
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 18.81
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 18.79
RNA-seq of stable and unstable section of human atherosclerotic plaques 18.43
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 18.32
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 18.3
RNA seq comparison between scrambled and shGRP78 cells 18.2
EWS-Fli and LNC regulated genes in comparison to GFP samples 18.05
Next Generation Sequencing of human SMA and healthy control Motor Neurons 18.04
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 18.04
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 17.91
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 17.58
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 17.58
RNA-seq of tumor cells following angiopellosis extravasation 17.54
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 17.36
circRNA-sequencing 17.15
Dermal endothelial cells of type 2 diabetic patients 17.09
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 17.0
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 16.96
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 16.8
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 16.72
The effect of PPARG inhibition on human angiomyolipoma cells 16.59
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 16.14
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 16.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 16.03
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 16.02
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 16.01
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 16.0
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 16.0
Identification of differentially expressed genes between senescence and senescence bypass cells 15.88
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 15.8
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 15.79
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 15.73
Effect of disulfiram treatment on pediatric high grade glioma 15.67
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 15.65
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 15.62
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 15.56
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 15.44
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 15.43
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 15.43
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 15.27
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 15.27
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.24
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 15.15
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 15.03
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 14.88
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 14.81
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 14.72
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 14.56
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 14.56
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 14.39
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 14.33
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 14.14
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.08
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 14.08
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 14.04
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 14.02
Genome-wide Analysis of Chromatin Interactions in Human Cells 13.86
Derivation and differentiation of haploid human embryonic stem cells 13.79
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 13.51
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 13.51
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 13.47
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 13.45
JAK dependent survival of ALK- ALCL 13.25
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 13.12
Selective expression of long non-coding RNAs in a breast cancer cell progression model 13.12
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 13.03
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 13.03
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 12.9
miR-93 Targets in Human Endothelial Cells 12.69
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 12.56
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 12.46
circRNA profile in hypopharyngeal cancer 12.38
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 12.22
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 12.19
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 11.92
11.89
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 11.87
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 11.84
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 11.71
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 11.56
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 11.56
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 11.52
Investigation about fibroblasts of different origins in culture 11.51
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.17
Epigenome regulation during epidermal lineage commitment [RNA-seq] 10.91
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 10.89
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 10.89
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 10.82
Functional astrocytes differentiated from hiPSCs 10.66
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 10.4
Differential gene expression in Jagged1 treated human dental pulp cells. 10.31
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 10.29
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 10.28
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 10.27
Fusion discovery in breast cancer cell line 10.25
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 10.22
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 10.07
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 10.0
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 9.98
CSL RNA-Seq on HKC and SCC cell lines 9.97
CSL 9.97
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 9.82
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 9.78
Gene Expression Profiling of WT and KDM3A Knocked out Cell 9.78
circNFIB suppresses lymphatic metastasis of pancreatic cancer 9.75
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 9.68
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 9.68
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 9.64
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 9.41
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.38
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.38
The effect of Abl kinases on non-small cell carcinoma global transcriptome 9.37
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 9.23
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 9.23
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 9.23
RNA seq_PDX2_SHP099 9.05
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 8.76
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 8.56
RNA Seq of HMVEC under hypoxia 8.53
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 8.47
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 8.31
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.2
RNA-seq analysis of the human fetal kidney. 8.14
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 8.05
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 7.95
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 7.93
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 7.85
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 7.85
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 7.72
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 7.59
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 7.59
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 7.47
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 7.29
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.19
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 6.35
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 6.35
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 6.34
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 6.16
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 6.11
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 6.11
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 5.98
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 5.9
RNA-Seq of Breast and Ovarian Cancer Cell Lines 5.85
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 5.79
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.78
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 5.68
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.67
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 5.61
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 5.61
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 5.61
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.57
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 5.56
Molecular Mechanisms of Endothelial Hyperpermeability 5.5
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.95
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 4.87
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.86
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 4.76
Gene expression alterations of pancreatic intraepithlial neoplasia 4.74
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.71
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.55
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 4.51
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 4.51
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 4.41
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.28
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 4.21
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.08
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.99
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.97
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.97
Transcriptome profiling of 5 human adenocarcinoma cell lines 3.95
Effects of transcription on genome - nuclear lamina interactions 3.46
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 3.46
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 3.3
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.3
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.23
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.21
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 3.12
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.76
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 2.75
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 2.75
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.72
Epigenome regulation during epidermal lineage commitment 2.66
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.62
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.62
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.49
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 2.4
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.33
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.32
Persistence of stem cell metabolism in cancers as a failure of differentiation 2.19
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.07
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.07
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.04
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.04
RNA sequencing of human pancreatic cancer cell lines 1.99
Aortic Valve Tissue: Stenosis vs. Sclerosis 1.95
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.88
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.82
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.82
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.72
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.58
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.51
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.35
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.3
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.29
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 1.27
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.26
NKX2.2 1.18
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 1.18
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 1.15
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.07
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.01
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.01
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.91
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.91
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.72
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.72
Engineering Patient-Specific Tissue Implants 0.62
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.58
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.58
Gene expression analysis of breast cancer cell-lines 0.46
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.46
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.04
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation